Bimal Rami, MD
Neurological Surgery · Baltimore, MDNPI 1194758508
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.2%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Stryker at 42.9% of the total. Reporting peaked in 2022 at $2,211 and has fallen 65.7% since, to $757 in 2025.
Across 77 payments — averaging $90.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Baxter Healthcare$2K
- Globus Medical$1K
- Providence Medical Technology, Inc.$281
- Nevro Corp.$136
- Orthofix Medical, Inc.$123
- plus $550 from 13 others
Across 3 payments — averaging $360.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orthofix Medical, Inc.$1K
What the payments were for
- Consulting fees$1,76425%
- Travel & lodging$1,37120%
- Food & beverage$3,85955%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 20 | $3,002 |
| Baxter Healthcare | 20 | $1,582 |
| Globus Medical | 6 | $1,320 |
| Providence Medical Technology, Inc. | 3 | $281 |
| Nevro Corp. | 4 | $136 |
| Orthofix Medical, Inc. | 4 | $123 |
| Penumbra, Inc. | 1 | $109 |
| Johnson & Johnson(2 entities) | 4 | $93 |
| Si-bone, Inc. | 3 | $76 |
| MML US, Inc. | 2 | $55 |
| Medtronic | 1 | $42 |
| Biocomposites Inc | 1 | $33 |
| Saluda Medical Americas, Inc. | 2 | $28 |
| SPR Therapeutics, Inc | 1 | $28 |
| Averitas Pharma Inc. | 1 | $26 |
| Relievant Medsystems, Inc. | 1 | $21 |
| Boston Scientific | 1 | $17 |
| Centinel Spine, LLC | 1 | $14 |
| Vertos Medical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOSEAL$1,050
- ELSA$700
- MARS 3VL Retractor$412
- TRITANIUM$276
- EVEREST SPINAL SYSTEM$273
- Excelsius - GPS$156
- IVS - VERTEBRAL AUGMENTATION PRODUCTS$135
- CASCADIA INTERBODY SYSTEM$128
- TISSEEL$121
- Penumbra System$109
- TACHOSIL$109
How this compares
$6,994 in reported general payments places this provider in the 60th percentile of 133 neurological surgery providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 53 | $496 |
| Tizanidine Hcl | 12 | $22 |
Paid to pharmacies, not to this prescriber.
Other neurological surgery in Baltimore
- Alexander CoonBaltimore$2.7M
- Charles SansurBaltimore$1.8M
- Nicholas TheodoreBaltimore$833K
- Daniel SciubbaBaltimore$789K
- Henry BremBaltimore$353K
- Ira GaronzikBaltimore$297K
- James ConwayBaltimore$273K
- Gustavo PradillaBaltimore$164K
- Timothy WithamBaltimore$141K
- Charles ParkBaltimore$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.